Abstract
Pathological changes of the vasculature are characterized by changes in Ca(2+) handling and alterations in gene expression. In neurons and other cell types, [Ca(2+)](i) often drives changes in gene expression. However, the relationship between Ca(2+) signaling and gene expression in vascular smooth muscle is not well understood. This study examines the ability of Ca(2+) influx through voltage-dependent, L-type Ca(2+) channels (VDCCs) and Ca(2+) release through ryanodine receptors (RyRs) to activate the transcription factor, cAMP-responsive element binding protein (CREB), and increase c-fos levels in intact cerebral arteries. Membrane depolarization increased the fraction of nuclei staining for phosphorylated CREB (P-CREB) and levels of c-fos mRNA in intact mouse cerebral arteries. Ryanodine, which inhibits RyRs, increased P-CREB staining and c-fos levels. Forskolin, an activator of adenylyl cyclase, and sodium nitroprusside, an NO donor, increased P-CREB and c-fos levels. Nisoldipine, an inhibitor of VDCCs, reversed the effects of depolarization and ryanodine on P-CREB and c-fos levels, but not the effects of forskolin or sodium nitroprusside. Inhibition of Ca(2+)/calmodulin-dependent protein kinase (CaM kinase) blocked increases in P-CREB and c-fos levels seen with membrane depolarization, suggesting that CaM kinase has an important role in the pathway leading from Ca(2+) influx to CREB-mediated changes in c-fos levels. Our data suggest that membrane depolarization increases [Ca(2+)](i) through activation of VDCCs, leading to increased P-CREB and c-fos, and that RyRs have a profound effect on this pathway by indirectly regulating Ca(2+) entry through VDCCs. These results provide the first evidence of Ca(2+) regulation of CREB and c-fos in arterial smooth muscle.
Original language | English |
---|---|
Journal | Circulation research |
Volume | 86( 7) |
Publication status | Published - 14 Apr 2000 |
Keywords
- Animals
- pharmacology: Benzylamines
- metabolism: Ca(2+)-Calmodulin Dependent Protein Kinase
- physiology: Calcium
- drug effects: Calcium Channels, L-Type
- antagonists & inhibitors: Calmodulin
- metabolism: Cyclic AMP Response Element-Binding Protein
- pharmacology: Diltiazem
- pharmacology: Enzyme Inhibitors
- pharmacology: Forskolin
- drug effects: Gene Expression Regulation
- Genes, fos
- pharmacology: Imidazoles
- physiology: Membrane Potentials
- Mice
- drug effects: Middle Cerebral Artery
- pharmacology: Nisoldipine
- pharmacology: Nitroprusside
- drug effects: Posterior Cerebral Artery
- pharmacology: Potassium
- genetics: Proto-Oncogene Proteins c-fos
- genetics: RNA, Messenger
- drug effects: Ryanodine Receptor Calcium Release Channel
- pharmacology: Sulfonamides
- Transcription, Genetic